There was also a slight trend towards a reduction in amyloid deposition rate in the SSRI group, notably in the frontal cortex, but the trend didn’t reach statistical significance ( P = 0.64) (Brendel et al., 2018).
1
—
—
There was also a slight trend towards a reduction in amyloid deposition rate in the SSRI group, notably in the frontal cortex, but the trend didn’t reach statistical significance ( P = 0.64) (Brendel et al., 2018).